## UPS: United Parcel Service, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 0.5% below STRENGTH zone (3.0-6.0%); PEG 1.33 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($92.57)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Fed set for rate cut as views split over inflation, jobs as priority**
- Source: S&P Global | 20251208T140907 | Neutral | Relevance: 64%
-  The Federal Reserve is expected to implement its third interest rate cut this week, facing a divided Federal Open Market Committee on whether to prioritize cooling inflation or bolstering the labor market. While some officials are concerned about persistently high inflation above the 2% target, others advocate for cuts due to signs of weakness in the labor market. The decision will likely be a 25-basis-point cut, followed by a potential pause, requiring Chair Jerome Powell to carefully manage expectations for 2026.

**2. Evercore ISI Adjusts Price Target on FedEx to $275 From $239, Maintains In Line Rating**
- Source: marketscreener.com | 20251209T114242 | Neutral | Relevance: 64%
-  Evercore ISI has raised its price target for FedEx (FDX) to $275 from $239, while maintaining an "In Line" rating for the company. This adjustment reflects an updated outlook on the shipping giant's valuation by the Evercore ISI analyst team. The new price target is slightly below the current average target price of $275.14 among analysts.

**3. FedEx : Economic Impact Report Highlights Singapore’s Key Role in Region, as Company Drives Connectivity and Innovation**
- Source: marketscreener.com | 20251208T094450 | Neutral | Relevance: 62%
-  FedEx Corp. (NYSE: FDX) has released its annual Global Economic Impact Report, underscoring Singapore's significant role within the region. The report highlights FedEx's vast worldwide network and its contribution to fostering innovation during fiscal year 2025. Produced in collaboration with Dun & Bradstreet, the study illustrates the positive "FedEx Effect" on individuals, businesses, and communities globally.

**4. Rivulet Capital LLC Has $15.65 Million Holdings in Rxo Inc $RXO**
- Source: MarketBeat | 20251208T120931 | Neutral | Relevance: 58%
- Rivulet Capital LLC increased its stake in Rxo Inc (NYSE:RXO) by 32.8% in Q2, with institutional investors now owning 92.73% of the company. Company insiders have also been buying shares, accumulating 40,250 shares in the last 90 days. Despite mixed analyst ratings and an average price target of $16.69, RXO missed its latest quarterly EPS and slightly missed revenue, although it showed a 34.6% year-over-year revenue increase.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 32.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.1% (+0.6%)
- Blackrock Inc.: 6.5% (-3.9%)
- State Street Corpora: 4.2% (+0.9%)
- Charles Schwab Inves: 3.6% (+1.9%)
- FMR, LLC: 2.8% (+25.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.33 suggests fair value with growth premium. Forward P/E 13.5x stretched relative to 4% growth. Quality metrics strong (ROE 34%). Balance sheet: $1.5B free cash flow. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $82.3B |
| Beta | 1.09 |
| 52W Range | $82.00 - $136.99 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.33 |
| Forward P/E | 13.5 |
| Current P/E | 14.1 |
| YoY Growth | 4.3% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.5% to 0.5% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.5pp (needs >3.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.53% (CS: 63) | Neutral |
| RSI_14 | 58.4 | Neutral |
| MACD Histogram | -0.07 | Bearish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.063x | Above |
| vs SMA200 | 1.006x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $96.97
- **Stop Loss:** $92.57 (4.5% risk)
- **Target:** $101.37 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $10,957.61
- **Portfolio %:** 10.96%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-01-27 (Est: $2.18)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.74 | +33.9% |
| 2025Q2 | $1.57 | $1.55 | -1.0% |
| 2025Q1 | $1.38 | $1.49 | +7.9% |
| 2024Q4 | $2.53 | $2.75 | +8.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*